Work

A framework for risk–benefit analysis of vaccines approved through accelerated pathways

Year: 2025

Type: article

Abstract: Funder: Coalition of Epidemic Preparedness Innovation

Source: Apollo (University of Cambridge)

Authors: Cracknell Daniels, Bethan, Endy, Timothy, Lewnard, Joseph, Di Fabio, Jose Luis, Cortes-Azuero, Oscar, Breugelmans, J Gabrielle, Cauchemez, Simon, Precioso, Alexander, Ko, Albert, Chandler, Rebecca E, Thomas, Stephen J, Lurie, Nicole, Salje, Henrik

Institutions: University of California, Berkeley, University of Cambridge, Institut Pasteur, Université Paris Cité, Yale University, Fundação Oswaldo Cruz, SUNY Upstate Medical University

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Coalition for Epidemic Preparedness Innovations, European Commission, Agence Nationale de la Recherche, Direction Générale de l’offre de Soins

Awards: G1979782309, G282427092, G2872175397, Institut Convergences pour l’étude de l’Emergence des Pathologies au Travers des Individus et des populatiONs, G7240651115, G7422929747, G7799207878, G8670608220

OpenAlex ID: W7124516507

FWCI:

Cites:

Cited by:

Related to: